Logo image of LFVN

LIFEVANTAGE CORP (LFVN) Stock Fundamental Analysis

NASDAQ:LFVN - Nasdaq - US53222K2050 - Common Stock - Currency: USD

15.4  -0.02 (-0.13%)

After market: 15.4 0 (0%)

Fundamental Rating

6

Taking everything into account, LFVN scores 6 out of 10 in our fundamental rating. LFVN was compared to 37 industry peers in the Personal Care Products industry. LFVN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LFVN is not valued too expensively and it also shows a decent growth rate. These ratings would make LFVN suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

LFVN had positive earnings in the past year.
LFVN had a positive operating cash flow in the past year.
Each year in the past 5 years LFVN has been profitable.
In the past 5 years LFVN always reported a positive cash flow from operatings.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

LFVN has a Return On Assets of 10.71%. This is amongst the best in the industry. LFVN outperforms 86.49% of its industry peers.
LFVN has a Return On Equity of 24.56%. This is amongst the best in the industry. LFVN outperforms 86.49% of its industry peers.
LFVN has a Return On Invested Capital of 17.20%. This is amongst the best in the industry. LFVN outperforms 86.49% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LFVN is significantly below the industry average of 13.75%.
The last Return On Invested Capital (17.20%) for LFVN is above the 3 year average (8.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.71%
ROE 24.56%
ROIC 17.2%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150 200

1.3 Margins

The Profit Margin of LFVN (3.46%) is comparable to the rest of the industry.
LFVN's Profit Margin has declined in the last couple of years.
LFVN has a Operating Margin of 5.11%. This is comparable to the rest of the industry: LFVN outperforms 59.46% of its industry peers.
In the last couple of years the Operating Margin of LFVN has declined.
The Gross Margin of LFVN (79.79%) is better than 97.30% of its industry peers.
LFVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.11%
PM (TTM) 3.46%
GM 79.79%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

LFVN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
LFVN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for LFVN has been reduced compared to 5 years ago.
There is no outstanding debt for LFVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

LFVN has an Altman-Z score of 4.76. This indicates that LFVN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.76, LFVN is in the better half of the industry, outperforming 70.27% of the companies in the same industry.
LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.76
ROIC/WACC1.92
WACC8.96%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

LFVN has a Current Ratio of 1.66. This is a normal value and indicates that LFVN is financially healthy and should not expect problems in meeting its short term obligations.
LFVN's Current ratio of 1.66 is in line compared to the rest of the industry. LFVN outperforms 45.95% of its industry peers.
LFVN has a Quick Ratio of 1.03. This is a normal value and indicates that LFVN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.03, LFVN perfoms like the industry average, outperforming 48.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.03
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

5

3. Growth

3.1 Past

LFVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
Measured over the past years, LFVN shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.69% on average per year.
LFVN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.57%.
LFVN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.40% yearly.
EPS 1Y (TTM)50%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%120%
Revenue 1Y (TTM)0.57%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%31.26%

3.2 Future

LFVN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.40% yearly.
The Revenue is expected to grow by 11.96% on average over the next years. This is quite good.
EPS Next Y36.59%
EPS Next 2Y36.75%
EPS Next 3Y33.4%
EPS Next 5YN/A
Revenue Next Year18.58%
Revenue Next 2Y13.55%
Revenue Next 3Y11.96%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.39 indicates a rather expensive valuation of LFVN.
Based on the Price/Earnings ratio, LFVN is valued a bit cheaper than 70.27% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, LFVN is valued a bit cheaper.
LFVN is valuated correctly with a Price/Forward Earnings ratio of 14.20.
LFVN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LFVN is cheaper than 78.38% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, LFVN is valued a bit cheaper.
Industry RankSector Rank
PE 21.39
Fwd PE 14.2
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

70.27% of the companies in the same industry are more expensive than LFVN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, LFVN is valued a bit cheaper than 78.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15
EV/EBITDA 12.14
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LFVN has a very decent profitability rating, which may justify a higher PE ratio.
LFVN's earnings are expected to grow with 33.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y36.75%
EPS Next 3Y33.4%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.04%, LFVN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.02, LFVN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, LFVN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.04%

5.2 History

LFVN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

26.61% of the earnings are spent on dividend by LFVN. This is a low number and sustainable payout ratio.
DP26.61%
EPS Next 2Y36.75%
EPS Next 3Y33.4%
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LIFEVANTAGE CORP

NASDAQ:LFVN (3/7/2025, 8:00:02 PM)

After market: 15.4 0 (0%)

15.4

-0.02 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners39.63%
Inst Owner Change9.23%
Ins Owners16%
Ins Owner Change-0.75%
Market Cap193.27M
Analysts82.5
Price Target33.15 (115.26%)
Short Float %13.67%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield 1.04%
Yearly Dividend0.55
Dividend Growth(5Y)N/A
DP26.61%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-03 2025-03-03 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.9%
Min EPS beat(2)-1.96%
Max EPS beat(2)61.77%
EPS beat(4)2
Avg EPS beat(4)13.46%
Min EPS beat(4)-34.64%
Max EPS beat(4)61.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.24%
Min Revenue beat(2)-7.05%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-5.92%
Min Revenue beat(4)-9.36%
Max Revenue beat(4)-1.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)364.29%
EPS NQ rev (1m)-25.76%
EPS NQ rev (3m)-31.95%
EPS NY rev (1m)2.19%
EPS NY rev (3m)3.56%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)18.89%
Revenue NY rev (1m)0.53%
Revenue NY rev (3m)17.06%
Valuation
Industry RankSector Rank
PE 21.39
Fwd PE 14.2
P/S 0.91
P/FCF 15
P/OCF 13.52
P/B 6.47
P/tB 6.52
EV/EBITDA 12.14
EPS(TTM)0.72
EY4.68%
EPS(NY)1.08
Fwd EY7.04%
FCF(TTM)1.03
FCFY6.66%
OCF(TTM)1.14
OCFY7.39%
SpS16.9
BVpS2.38
TBVpS2.36
PEG (NY)0.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.71%
ROE 24.56%
ROCE 26.46%
ROIC 17.2%
ROICexc 36.36%
ROICexgc 36.85%
OM 5.11%
PM (TTM) 3.46%
GM 79.79%
FCFM 6.07%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
ROICexc(3y)14.83%
ROICexc(5y)33.63%
ROICexgc(3y)15.14%
ROICexgc(5y)35.34%
ROCE(3y)12.51%
ROCE(5y)23.24%
ROICexcg growth 3Y-29.46%
ROICexcg growth 5Y-27.73%
ROICexc growth 3Y-29.25%
ROICexc growth 5Y-26.49%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
F-Score7
Asset Turnover3.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 42.68%
Cap/Sales 0.66%
Interest Coverage 570.63
Cash Conversion 101.03%
Profit Quality 175.49%
Current Ratio 1.66
Quick Ratio 1.03
Altman-Z 4.76
F-Score7
WACC8.96%
ROIC/WACC1.92
Cap/Depr(3y)65.13%
Cap/Depr(5y)79.97%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.23%
Profit Quality(3y)232.22%
Profit Quality(5y)185.98%
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%120%
EPS Next Y36.59%
EPS Next 2Y36.75%
EPS Next 3Y33.4%
EPS Next 5YN/A
Revenue 1Y (TTM)0.57%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%31.26%
Revenue Next Year18.58%
Revenue Next 2Y13.55%
Revenue Next 3Y11.96%
Revenue Next 5YN/A
EBIT growth 1Y193.9%
EBIT growth 3Y-37.33%
EBIT growth 5Y-15.06%
EBIT Next Year89.76%
EBIT Next 3Y42.02%
EBIT Next 5YN/A
FCF growth 1Y1363.75%
FCF growth 3Y-7.39%
FCF growth 5Y-8.22%
OCF growth 1Y365.51%
OCF growth 3Y-9.16%
OCF growth 5Y-7.27%